When examining the transcriptional profiles of MS patient cells as compared to controls, CSF exhibited differences in cell type composition, including an enrichment of myeloid dendritic cells and the expansion of CD4+ cytotoxic T cells and late stage B cells. This evidence concerns the gene CD4 and myeloid sarcoma.